Mary Van Beusekom | News Writer | CIDRAP NewsNov 18, 2020Supply chain issues could hinder vaccine rollout, and EUA data must be transparent, the report says.
GAO highlights COVID vaccine supply chain, drug transparency issues
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- 1 in 5 adults with diabetes experienced functional decline during pandemic
- Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen
- Study shows increase in serious alcohol-related complications early in pandemic
- Nasal cells offer clues about why COVID-19 is typically milder in children